期刊文献+

维持性血液透析合并继发性甲状旁腺功能亢进患者骨代谢及骨密度变化 被引量:39

Bone metabolism and bone mineral density in maintenance hemodialysis patients with secondary hyperparathyroidism
下载PDF
导出
摘要 目的观察维持性血液透析(maintenance hemodialysiS,MHD)合并继发性甲状旁腺功能亢进(secondary hyperparathyroidism,SHPT)患者骨代谢指标及骨密度(bone mineral density,BMD)变化。方法86例入选MHD合并SHPT患者按全段甲状旁腺激素(intact parathyroid,iPTH)水平分为A(150-300pg/ml,n=23)、B(300-600pg/ml,n=21)、C(6001000pg/ml,n-24)、D(〉1000pg/ml,n=18)4组;按是否合并糖尿病分为糖尿病组、非糖尿病组。测定腰椎、股骨BMD;检测iPTH、白蛋白、钙、磷、碱性磷酸酶水平。观察各组患者以上指标变化,分析iPTH与其相关性。结果①B、C组血磷(LSDf=2.030,P=0.049)、L1-L4BMD(LSD—t=4.591,P〈0.001)和L1-L4年轻成人T值(LSD—V=-4.813,P〈0.001)差异有统计学意义;②A、B、C、D组随着iPTH平的升高,左侧股骨BMD(1.07±0.18,1.00±0.16,0.84±0.15,0.78±0.43,F=5.616,P-O.001)、左侧股骨年轻成人T值(1.00±0.25,0.12±1.24,-1.08±1.20,1.05±30,F=16.377,P=-0.001)、左侧股骨Wards三角BMD(1.00±0.25,0.91±0.25,0.66±0.09,0.62±0.03,F6.915,P〈0.001)、左侧股骨Wards三角年轻成人T值(0.84±1.68,0.18±1.62,-1.45±0.60,-1.75±0.19,F=14.928,P〈0.001)呈下降趋势,4组间比较差异有统计学意义;③非糖尿病组iPTH水平明显高于糖尿病组(t=--7.387,P〈0.001),而左侧股骨BMD(t=-2.414,P=0.018)、左侧股骨年轻成人T值(F5.477,P〈0.001)、左侧股骨Wards三角BMD(t-3.252,P=-0.020)、左侧股骨Wards三角年轻成人T值(t=7.758,P〈0.001)均明显低于糖尿病组;④相关性分析:iPTH与ALP呈正相关(F0.782,P〈0.001),与左侧股骨BMD(R=-0.532,P=0.025)、左侧股骨年轻成人T值(r=-0.520,P=0.004)、左侧股骨Wards三角BMD(r=0.514,P〈0.001)、左侧股骨Wards三角年轻成人T值(r=-0.512,P〈0.001)呈负相关。结论MHD合并SHPT患者血磷可能成为反映腰椎骨代谢的标志物;iPTH水平可预估MHD合并SHPT患者股骨尤其是股骨Wards三角骨代谢情况。 Objective To observe the changes of bone metabolism and bone mineral density (BMD) in the maintenance hemodialysis (MHD) patients with secondary hyperparathyroidism (SHPT). Methods Eighty-six MHD patients with SHPT were enrolled in this study and were assigned according to their serum intact parathyroid (iPTH) level into 4 groups, group A (150-300 pg/ml, n=23), group B (300-600 pg/ml, n= 21), group C (600- 1000 pg/ml, n=24) and group D (〉 1000 pg/ml, n=1 8), and according to the presence or absence of diabetes into diabetes group and non-diabetes group. BMD and serum albumin, calcium, phosphorus, alkaline phosphatase (ALP) and iPTH were assayed. Changes of these parameters in different groups and their relevance to iPTH levels were analyzed. Results Serum phosphorus (LSD-t=-2.030, P=0.049), L1-L4 BMD (LSD-t=4.591, P〈0.001) and young adult L1-L4 T value (LSD-t=4.813, P〈0.001) were significantly different between group B and group C. iPTH was significantly higher in non-diabetes group than in diabetes group (t=-7.387, P〈0.001), while left femur BMD (t=-2.414, P =0.018), young adult left femur T value (t=5.477, P〈0.001), left femoral Wards triangle BMD (t=-3.252, P=0.020) and young adult left femoral Wards triangle T value (t=7.758, P〈0.001) were significantly lower in non-diabetes group than in diabetes group ( P〈 0.05). In groups A, B, C and D, left femur BMD (1.07±0.18, 1.00±0.16, 0.84±0.15 and 0.78±0.43 respective- ly; F=-5.616, P=0.001), young adult left femur T value (1.00±0.25, 0.12±1.24, -1.08±1.20 and -1.05±30 respectively; F=16.377, P =0.001), left femoral Wards triangle BMD (1.00±0.25, 0.91±0.25, 0.66±0.09 and 0.62±0.03 respectively; F=-6.915, P〈0.001) and young adult left femoral Wards triangle T value (0.84±1.68, 0.18±1.62, - 1.45±0.60 and -1.75±0.19 respectively; F=-14.928, P〈0.001) decreased gradually along with the increase of serum iPTH level (P〈0.01). Correlation study revealed that iPTH level was positively correlated with ALP (r=0.782, P〈0.001), and negatively correlated with left femur BMD (r=-0.532, P=0.025), young adult left femur T value (r=-0.520, P=0.004), left femoral Wards triangle BMD (r=-0.514, P〈0.001), and young adult left femoral Wards triangle T value (r=-0.512, P〈0.001). Conclusions In MHD patients with SHPT, hyperphosphatemia may become a marker of lumbar bone metabolism abnormalities, and serum iPTH level can be used to estimate bone metabolism of femur, especially that of femoral Wards triangle.
出处 《中国血液净化》 2016年第7期332-335,共4页 Chinese Journal of Blood Purification
关键词 维持性血液透析 甲状旁腺功能亢进 继发性 骨密度 Maintenance hemodialysis Hyperparathyroidism Secondary Bone mineral density
  • 相关文献

参考文献17

  • 1HOrl WH. The clinical consequences of secondary hyper parathyroidism:focus on clinical outcomes[J]. Nephrol Dial Transplant, 2004, 19 (Suppl 5):V2 VS.
  • 2中华医学会肾脏病学分会.慢性肾脏病矿物质和骨异常诊治指导[J].中华肾脏病杂志,2014,30(z1):20-30.
  • 3王质刚.血液净化学.3版[M].北京:北京科学技术出版社,2010.
  • 4Formica M, Bostieardo G. Dialysis adequacy and Kt/V [Jl. Ital Nefrol. 2011;28(2):152-156.
  • 5Klawansky S, Komaroff E, Gavanaugh PF, et al. Rela- tionship between age, renal function and bone mineral density in the US population[J]. Osteoporos Int, 2003, 14(7):570-576.
  • 6Yenchek RH, Ix JH, Shlipak MG, et al. Bone mineral density and fracture risk in older individuals with CKD[J]. Clin J Am Soc Nephrol, 2012, 7(7): i130-i136.
  • 7Marshall D, ]ohnell O, Wedel H. Meta analysis of how well measures of bone mineral density predict occur- rence of osteoporotin fractures[J~, g~J, 1996, 312 (7041):1254-1259.
  • 8Iimori S, ~ori Y, Akita W, et al. Diagnostic useful ness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients-a single center cohort study[J]. Nepbrol Dial Transplant, 2012, 27(1):345-351.
  • 9Disthabanehong S, Jongjirasiri S, Adirekkiat S, et al. Low hip bone mineral density predicts mortality in maintenance hemodialysis patients: a five year fol- low up study[J]. Blood Purif, 2014, 37(1): 33-38.
  • 10Ersoy FF. Osteoporosis in the elderly with chronic kidney disease[]]. Int Urol Nephrol, 2007,39(1):321- 331.

二级参考文献48

共引文献57

同被引文献317

引证文献39

二级引证文献195

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部